These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Response of tardive and L-dopa-induced dyskinesias to antidepressants. el-Awar M; Freedman M; Seeman P; Goldenberg L; Little J; Solomon P Can J Neurol Sci; 1987 Nov; 14(4):629-31. PubMed ID: 3690436 [TBL] [Abstract][Full Text] [Related]
4. [Depression is common in Parkinson disease. Limited studies on symptoms and treatment]. Hagell P; Odin P; Freccero-Rosman K; Träskman-Bendz L; Lindvall O Lakartidningen; 1994 Nov; 91(46):4270, 4275-6. PubMed ID: 7808129 [No Abstract] [Full Text] [Related]
5. Depression in Parkinson's disease. Pharmacological characteristics and treatment. Tom T; Cummings JL Drugs Aging; 1998 Jan; 12(1):55-74. PubMed ID: 9467687 [TBL] [Abstract][Full Text] [Related]
6. Drug Choices and Advancements for Managing Depression in Parkinson's Disease. Assogna F; Pellicano C; Savini C; Macchiusi L; Pellicano GR; Alborghetti M; Caltagirone C; Spalletta G; Pontieri FE Curr Neuropharmacol; 2020; 18(4):277-287. PubMed ID: 31622207 [TBL] [Abstract][Full Text] [Related]
7. Anti-depressive treatment in Parkinson's disease. A controlled trial of the effect of nortriptyline in patients with Parkinson's disease treated with L-DOPA. Andersen J; Aabro E; Gulmann N; Hjelmsted A; Pedersen HE Acta Neurol Scand; 1980 Oct; 62(4):210-9. PubMed ID: 7010875 [TBL] [Abstract][Full Text] [Related]
8. [Pseudopheochromocytoma in Parkinson disease and depression]. Jähnel M Psychiatr Prax; 2003 May; 30 Suppl 2():S64-5. PubMed ID: 14509040 [TBL] [Abstract][Full Text] [Related]
9. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease. Meco G; Bernardi S Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377 [TBL] [Abstract][Full Text] [Related]
10. [Dystonia preceding dopa-responsive parkinsonism--heterogeneous clinical features]. Miwa H; Mizuno Y No To Shinkei; 1996 Feb; 48(2):149-54. PubMed ID: 8865694 [TBL] [Abstract][Full Text] [Related]
11. [Depression and Parkinson syndrome]. Schnaberth G Wien Med Wochenschr; 1986 Aug; 136(15-16):391-3. PubMed ID: 2878539 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of L-dopa and subthalamic stimulation on depressive symptoms and hedonic tone in Parkinson's disease. Witt K; Daniels C; Herzog J; Lorenz D; Volkmann J; Reiff J; Mehdorn M; Deuschl G; Krack P J Neuropsychiatry Clin Neurosci; 2006; 18(3):397-401. PubMed ID: 16963590 [TBL] [Abstract][Full Text] [Related]
13. [Therapeutic strategies and tactics in parkinsonism]. Birkmayer W Wien Med Wochenschr; 1986 Aug; 136(15-16):408-11. PubMed ID: 3097964 [TBL] [Abstract][Full Text] [Related]
14. Bupropion in the treatment of depression in Parkinson's disease. Załuska M; Dyduch A Int Psychogeriatr; 2011 Mar; 23(2):325-7. PubMed ID: 20809995 [TBL] [Abstract][Full Text] [Related]
16. Treating parkinsonism in the era of levodopa. McFarland HR Am Fam Physician; 1975 Sep; 12(3):99-104. PubMed ID: 240264 [No Abstract] [Full Text] [Related]
17. [L-dopa/benserazide during pregnancy in a patient with juvenile parkinsonism]. Arai H; Shinotoh H; Hattori T Rinsho Shinkeigaku; 1997 Mar; 37(3):264-5. PubMed ID: 9217430 [TBL] [Abstract][Full Text] [Related]
18. Altered Cortico-Limbic Network Connectivity in Parkinsonian Depression: The Effect of Antidepressants. Morgan HE; Ledbetter CR; Ferrier C; Zweig RM; Disbrow EA J Parkinsons Dis; 2018; 8(3):429-440. PubMed ID: 30124452 [TBL] [Abstract][Full Text] [Related]
19. Treatment options for depression and psychosis in Parkinson's disease. Poewe W; Seppi K J Neurol; 2001 Sep; 248 Suppl 3():III12-21. PubMed ID: 11697683 [TBL] [Abstract][Full Text] [Related]
20. [High dose L-dopa infusion during general anesthesia for gastrectomy in a patient with parkinsonism]. Horai T; Nishiyama T; Yamamoto H; Hanaoka K Masui; 2002 Jan; 51(1):42-5. PubMed ID: 11840662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]